From the included studies, the challenge with using mucin gene expression in isolation as diagnostic biomarkers in OGC arises from the fact that these expression profiles also change in benign pathology including chronic gastritis and peptic ulcers [71]. This evidence concerns the gene MUC5AC and Peptic ulcer.